Pacific Biosciences of California, Inc.

NasdaqGS:PACB 株式レポート

時価総額:US$603.9m

Pacific Biosciences of California マネジメント

マネジメント 基準チェック /24

Pacific Biosciences of Californiaの CEO はChristian O. Henryで、 Sep2020年に任命され、 の在任期間は 4.17年です。 の年間総報酬は$ 8.05Mで、 8.6%給与と91.4%のボーナス(会社の株式とオプションを含む)で構成されています。 は、会社の株式の0.14%を直接所有しており、その価値は$ 860.82K 。経営陣と取締役会の平均在任期間はそれぞれ4年と11.8年です。

主要情報

Christian O. Henry

最高経営責任者

US$8.0m

報酬総額

CEO給与比率8.6%
CEO在任期間4.2yrs
CEOの所有権0.1%
経営陣の平均在職期間4yrs
取締役会の平均在任期間11.8yrs

経営陣の近況

Recent updates

Pacific Biosciences' Cost Cuts Won't Offset Rising Competition

Nov 12

Pacific Biosciences of California, Inc. (NASDAQ:PACB) Stock Rockets 56% But Many Are Still Ignoring The Company

Nov 07
Pacific Biosciences of California, Inc. (NASDAQ:PACB) Stock Rockets 56% But Many Are Still Ignoring The Company

Health Check: How Prudently Does Pacific Biosciences of California (NASDAQ:PACB) Use Debt?

Oct 16
Health Check: How Prudently Does Pacific Biosciences of California (NASDAQ:PACB) Use Debt?

Even With A 37% Surge, Cautious Investors Are Not Rewarding Pacific Biosciences of California, Inc.'s (NASDAQ:PACB) Performance Completely

Sep 20
Even With A 37% Surge, Cautious Investors Are Not Rewarding Pacific Biosciences of California, Inc.'s (NASDAQ:PACB) Performance Completely

Pacific Biosciences: A Speculative Play On Long-Read Genomics Sequencing

Aug 21

Take Care Before Jumping Onto Pacific Biosciences of California, Inc. (NASDAQ:PACB) Even Though It's 33% Cheaper

Jul 02
Take Care Before Jumping Onto Pacific Biosciences of California, Inc. (NASDAQ:PACB) Even Though It's 33% Cheaper

We Think Pacific Biosciences of California (NASDAQ:PACB) Has A Fair Chunk Of Debt

Jun 08
We Think Pacific Biosciences of California (NASDAQ:PACB) Has A Fair Chunk Of Debt

Pacific Biosciences: Navigating Rough Waters In Gene Sequencing Seas

Jun 03

These Analysts Think Pacific Biosciences of California, Inc.'s (NASDAQ:PACB) Sales Are Under Threat

Apr 25
These Analysts Think Pacific Biosciences of California, Inc.'s (NASDAQ:PACB) Sales Are Under Threat

It's Down 25% But Pacific Biosciences of California, Inc. (NASDAQ:PACB) Could Be Riskier Than It Looks

Apr 16
It's Down 25% But Pacific Biosciences of California, Inc. (NASDAQ:PACB) Could Be Riskier Than It Looks

Pacific Biosciences' Pivot: From Shareholder Dilution To Expansion And Leadership

Mar 19

Pacific Biosciences: Strong Cash And Doubling Revenue Signal Investment Growth

Feb 08

With A 34% Price Drop For Pacific Biosciences of California, Inc. (NASDAQ:PACB) You'll Still Get What You Pay For

Feb 01
With A 34% Price Drop For Pacific Biosciences of California, Inc. (NASDAQ:PACB) You'll Still Get What You Pay For

What You Can Learn From Pacific Biosciences of California, Inc.'s (NASDAQ:PACB) P/S

Dec 18
What You Can Learn From Pacific Biosciences of California, Inc.'s (NASDAQ:PACB) P/S

Does Pacific Biosciences of California (NASDAQ:PACB) Have A Healthy Balance Sheet?

Nov 13
Does Pacific Biosciences of California (NASDAQ:PACB) Have A Healthy Balance Sheet?

The Price Is Right For Pacific Biosciences of California, Inc. (NASDAQ:PACB) Even After Diving 27%

Aug 28
The Price Is Right For Pacific Biosciences of California, Inc. (NASDAQ:PACB) Even After Diving 27%

Is Pacific Biosciences of California, Inc. (NASDAQ:PACB) Trading At A 32% Discount?

Jul 31
Is Pacific Biosciences of California, Inc. (NASDAQ:PACB) Trading At A 32% Discount?

Is It Time To Consider Buying Pacific Biosciences of California, Inc. (NASDAQ:PACB)?

Jul 06
Is It Time To Consider Buying Pacific Biosciences of California, Inc. (NASDAQ:PACB)?

Pacific Biosciences of California (NASDAQ:PACB) Is Carrying A Fair Bit Of Debt

May 25
Pacific Biosciences of California (NASDAQ:PACB) Is Carrying A Fair Bit Of Debt

Is Now The Time To Look At Buying Pacific Biosciences of California, Inc. (NASDAQ:PACB)?

Mar 29
Is Now The Time To Look At Buying Pacific Biosciences of California, Inc. (NASDAQ:PACB)?

Is Pacific Biosciences of California, Inc. (NASDAQ:PACB) Worth US$8.8 Based On Its Intrinsic Value?

Feb 26
Is Pacific Biosciences of California, Inc. (NASDAQ:PACB) Worth US$8.8 Based On Its Intrinsic Value?

CEO報酬分析

Pacific Biosciences of California の収益と比較して、Christian O. Henry の報酬はどのように変化したか?
日付総報酬給与会社業績
Sep 30 2024n/an/a

-US$394m

Jun 30 2024n/an/a

-US$400m

Mar 31 2024n/an/a

-US$297m

Dec 31 2023US$8mUS$695k

-US$307m

Sep 30 2023n/an/a

-US$309m

Jun 30 2023n/an/a

-US$319m

Mar 31 2023n/an/a

-US$321m

Dec 31 2022US$7mUS$667k

-US$314m

Sep 30 2022n/an/a

-US$299m

Jun 30 2022n/an/a

-US$206m

Mar 31 2022n/an/a

-US$175m

Dec 31 2021US$3mUS$650k

-US$181m

Sep 30 2021n/an/a

-US$37m

Jun 30 2021n/an/a

-US$77m

Mar 31 2021n/an/a

-US$59m

Dec 31 2020US$13mUS$195k

US$29m

Sep 30 2020n/an/a

-US$46m

Jun 30 2020n/an/a

-US$51m

Mar 31 2020n/an/a

-US$53m

Dec 31 2019US$100kn/a

-US$84m

Sep 30 2019n/an/a

-US$115m

Jun 30 2019n/an/a

-US$111m

Mar 31 2019n/an/a

-US$109m

Dec 31 2018US$88kn/a

-US$103m

報酬と市場: Christian O.の 総報酬 ($USD 8.05M ) は、 US市場 ($USD 3.18M ) の同規模の企業の平均を上回っています。

報酬と収益: Christian O.の報酬は増加しましたが、会社は利益を上げていません。


CEO(最高経営責任者

Christian O. Henry (56 yo)

4.2yrs

在職期間

US$8,046,575

報酬

Mr. Christian O. Henry, MBA, served as Independent Director at CM Life Sciences III Inc. since April 07, 2021 until December 2021. He has been President and Chief Executive Officer at Pacific Biosciences o...


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Christian O. Henry
President4.2yrsUS$8.05m0.14%
$ 860.8k
Susan Kim
Chief Financial Officer4.2yrsUS$2.52m0.043%
$ 262.0k
Mark Van Oene
Chief Operating Officer3.8yrsUS$4.60m0.12%
$ 701.0k
Jeff Eidel
Chief Commercial Officer2.3yrsUS$2.53m0.050%
$ 299.7k
Stephen Turner
Co-Founder24.3yrsUS$466.76kデータなし
Michele Farmer
VP & Chief Accounting Officer3.5yrsデータなし0.013%
$ 80.3k
Brett Atkins
General Counsel & Corporate Secretaryno dataデータなしデータなし
Natalie Welch
Chief People Officerno dataデータなしデータなし

4.0yrs

平均在職期間

49.5yo

平均年齢

経験豊富な経営陣: PACBの経営陣は 経験豊富 であると考えられます ( 4年の平均在職年数)。


取締役

名称ポジション在職期間報酬所有権
Christian O. Henry
President6.3yrsUS$8.05m0.14%
$ 860.8k
William Ericson
Independent Director20.8yrsUS$259.00k0.0069%
$ 41.7k
Lucy Shapiro
Independent Director12.2yrsUS$255.00k0%
$ 0
John Milligan
Independent Chairman11.3yrsUS$297.00k0.040%
$ 243.7k
Harry Gray
Member of the Scientific Advisory Boardno dataデータなしデータなし
Joseph Bonventre
Member of the Scientific Advisory Boardno dataデータなしデータなし
Randall Livingston
Independent Director15.8yrsUS$265.00k0%
$ 0
Harold Craighead
Member of the Scientific Advisory Boardno dataデータなしデータなし
Roger Kornberg
Member of the Scientific Advisory Boardno dataデータなしデータなし
Watt Webb
Member of the Scientific Advisory Boardno dataデータなしデータなし
Kenneth Johnson
Member of the Scientific Advisory Boardno dataデータなしデータなし
Jay Shendure
Chairman of Scientific Advisory Board2yrsデータなしデータなし

11.8yrs

平均在職期間

70yo

平均年齢

経験豊富なボード: PACBの 取締役会 は経験豊富で 経験豊富 です ( 11.8年の平均在任期間)。